Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis
NCT05750966 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 440
Last updated 2026-02-05
Summary
The goal of this multicentre randomized controlled trial is to investigate if a very short-course of antibiotics (1 day) for cholangitis after adequate drainage is non-inferior with respect to clinical cure in comparison with a standard course of antibiotics (4 to 7 days). Secondary objectives include:
* Will a one-day course of antibiotics for cholangitis after adequate drainage be non-inferior with respect to relapse of cholangitis and mortality in comparison with a standard course of antibiotics?
* Will a one-day course of antibiotics for cholangitis after adequate drainage result in less adverse drug events in comparison with a standard course of antibiotics?
* Will a one-day course of antibiotics for cholangitis after adequate drainage reduce length of hospital stay?
* Will a one-day course of antibiotics for cholangitis after adequate drainage improve quality of life?
* Will a one-day course of antibiotics for cholangitis after adequate drainage be cost-effective?
Conditions
- Cholangitis
Interventions
- DRUG
-
cefrtriaxone, gentamicin, cefuroxim, ciprofloxin or other antibiotics according to local guideline (24 hours)
The duration of antibiotics is 24 hours after adequate biliary drainage. The choice of antibiotics will be according to local protocol and/or national Dutch SWAB guidelines. The most common antibiotics are described above, but this can differ based on allergies, local protocol or previous cultures. Drug classes may include: aminoglycosides, carbapenems, cefalosporins, fluorquinolones, sulfonamides, penicillines.
- DRUG
-
cefrtriaxone, gentamicin, cefuroxim, ciprofloxin or other antibiotics according to local guideline (4 to 7 days)
The duration of antibiotics is 4 to 7 days after adequate biliary drainage. The choice of antibiotics will be according to local protocol and/or national Dutch SWAB guidelines. The most common antibiotics are described above, but this can differ based on allergies, local protocol or previous cultures. Drug classes may include: aminoglycosides, carbapenems, cefalosporins, fluorquinolones, sulfonamides, penicillines.
Sponsors & Collaborators
-
ZonMw: The Netherlands Organisation for Health Research and Development
collaborator OTHER -
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-19
- Primary Completion
- 2026-03-01
- Completion
- 2026-09-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Faecal Bacteriotherapy for Postantibiotic Diarrhoea in Critically Ill Patients
NCT05430269 ·Status: UNKNOWN ·Phase: NA
-
Metagenomic and Metabolomic Reconstitution of Gut Microbiota After Broad Spectrum Antibiotic Therapy
NCT04171466 ·Status: COMPLETED ·Phase: NA
-
Diverticulitis: Antibiotics or Close Observation?
NCT01111253 ·Status: UNKNOWN ·Phase: PHASE4
-
Antibiotics for the Treatment of Ulcerative Colitis
NCT00355602 ·Status: COMPLETED ·Phase: NA
-
Ciprofloxacin Multiple Dose for Adult Cholera
NCT00741052 ·Status: COMPLETED ·Phase: PHASE3
-
Trial Assessing the Efficacy of a Short Course of Intravenous Antibiotic Followed by Oral Antibiotic in Uncomplicated Acute Diverticulitis
NCT00917592 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Safety & Efficacy of Oral Ciprodiazole Versus Currently Used Ciprofloxacin & Metronidazole
NCT05863832 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea
NCT00196794 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Patients With Acute Pouchitis Treated With Antibiotics
NCT05252273 ·Status: SUSPENDED
-
Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP)
NCT02782325 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis
NCT02606032 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea
NCT00382304 ·Status: COMPLETED ·Phase: PHASE2
-
Secondary Prevention of Clostridioides Difficile Using Vancomycin
NCT06979609 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Decolonization of Carbapenem-resistant Enterobacterales (CRE) in Patients With Faecal Carriage of CRE With Neomycin
NCT05593601 ·Status: UNKNOWN ·Phase: PHASE4
-
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
NCT01085760 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea
NCT00106509 ·Status: COMPLETED ·Phase: PHASE3
-
Intracolonic Vancomycin Therapy in Severe C. Diff Colitis
NCT01346059 ·Status: TERMINATED ·Phase: NA
-
Once Daily Metronidazole for Perforated Appendicitis
NCT02561117 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection
NCT01259726 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Loperamide for C. Difficile Colitis and Other Diarrheal Diseases Associated With Antibiotic Therapy
NCT00591357 ·Status: SUSPENDED ·Phase: PHASE4
-
Challenge Non-Typhoidal Salmonella (CHANTS) Study
NCT05870150 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cholera Anti-Secretory Treatment Trial
NCT04150250 ·Status: COMPLETED ·Phase: PHASE2
-
AssessmeNT of the Incidence of Clostridium Difficile Infections in Hospitalized Patients on Antibiotic TrEatment
NCT02896244 ·Status: COMPLETED
-
The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart Surgery
NCT03939273 ·Status: UNKNOWN ·Phase: NA
-
The Role of Short-course Ceftriaxone Therapy in the Treatment of Severe Nontyphoidal Salmonella Enterocolitis
NCT01278017 ·Status: UNKNOWN ·Phase: PHASE4